Vivos Therapeutics, Inc. SEC filings VVOS
Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 2, 2026 | — |
| DEF 14A | Proxy statement | Oct 29, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Oct 26, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Oct 26, 2026 | Sep 14, 2026 |
| PRER14A | Filing | Oct 21, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 21, 2026 | Oct 20, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 1, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Sep 8, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 8, 2026 | Aug 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 3, 2026 | — |
| 4 | Insider transaction | Aug 26, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2026 | Aug 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 11, 2026 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 3, 2026 | Jul 31, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Jul 15, 2026 | — |
| 4 | Insider transaction | Jul 15, 2026 | Jun 30, 2026 |
| 3 | Initial insider ownership | Jul 15, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Other events
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Material agreement, New debt, Listing notice, Unregistered share sale, Regulation FD disclosure
|
Jun 8, 2026 | Jun 8, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| EFFECT | Filing | May 8, 2026 | — |
| 424B3 | Prospectus | May 8, 2026 | — |
| CORRESP | Letter to the SEC | May 6, 2026 | — |
| S-3/A | Filing | Apr 30, 2026 | — |
| 8-K |
Current report
Listing notice
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 15, 2026 | Apr 15, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Apr 10, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2026 | Apr 3, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 2, 2026 | — |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| UPLOAD | Letter from the SEC | Feb 23, 2026 | — |
| S-3 | Shelf registration | Feb 17, 2026 | — |
| 3 | Initial insider ownership | Feb 13, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 16, 2026 | Jan 16, 2026 |
| 424B3 | Prospectus | Jan 14, 2026 | — |
| EFFECT | Filing | Jan 7, 2026 | — |
| POS AM | Filing | Jan 2, 2026 | — |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 5, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 19, 2025 | Nov 19, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 4, 2025 | Nov 4, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| DEF 14A | Proxy statement | Sep 29, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Other events
|
Sep 18, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Sep 12, 2025 | Sep 12, 2025 |
| 424B5 | Prospectus supplement | Sep 12, 2025 | — |
| EFFECT | Filing | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| S-3/A | Filing | Sep 5, 2025 | — |
| 8-K/A |
Amended current report
Acquisition or sale of assets, Other events
|
Aug 25, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 20, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 14, 2025 | — |
| 3 | Initial insider ownership | Jun 20, 2025 | Jun 9, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jun 16, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jun 13, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Auditor change
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 23, 2025 | May 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 17, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 14, 2025 | Feb 14, 2025 |
| UPLOAD | Letter from the SEC | Feb 13, 2025 | — |
| S-3 | Shelf registration | Feb 11, 2025 | — |
| 424B1 | Filing | Jan 31, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 29, 2025 | — |
| S-1/A | Amended registration statement | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2025 | — |
| S-1 | Registration statement | Jan 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 30, 2024 | — |
| 424B5 | Prospectus supplement | Dec 26, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 20, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| DEFA14A | Additional proxy material | Nov 6, 2024 | — |
| DEF 14A | Proxy statement | Oct 7, 2024 | Oct 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 24, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 8-K | Current report | Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 424B1 | Filing | Aug 8, 2024 | — |
| EFFECT | Filing | Aug 7, 2024 | — |
| CORRESP | Letter to the SEC | Aug 5, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2024 | — |
| S-3 | Shelf registration | Jul 30, 2024 | — |
| 10-K/A | Amended annual report | Jul 30, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jul 10, 2024 | Jul 10, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 25, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Listing notice
|
May 17, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 6, 2024 | May 3, 2024 |
| EFFECT | Filing | Apr 26, 2024 | — |
| 424B1 | Filing | Apr 26, 2024 | — |
| CORRESP | Letter to the SEC | Apr 24, 2024 | — |
| S-1/A | Amended registration statement | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2024 | — |
| S-1 | Registration statement | Apr 9, 2024 | — |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 28, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 15, 2024 | Feb 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| EFFECT | Filing | Dec 1, 2023 | — |
| 424B1 | Filing | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Nov 30, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 30, 2023 | Nov 30, 2023 |
| S-1/A | Amended registration statement | Nov 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| S-1 | Registration statement | Nov 22, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 424B3 | Prospectus | Nov 3, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 27, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 21, 2023 | Sep 21, 2023 |
| DEFA14A | Additional proxy material | Sep 14, 2023 | — |
| DEFA14A | Additional proxy material | Sep 6, 2023 | — |
| DEF 14A | Proxy statement | Aug 28, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2023 | Aug 21, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2023 | Aug 16, 2023 |
| 10-Q | Quarterly report | Aug 16, 2023 | Jun 30, 2023 |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 20, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Results of operations
|
Jun 8, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | Jun 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Listing notice
|
May 26, 2023 | May 26, 2023 |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Auditor change, Other events
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Other events
|
Mar 2, 2023 | Mar 2, 2023 |
| 424B1 | Filing | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| EFFECT | Filing | Feb 8, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2023 | — |
| S-1 | Registration statement | Jan 30, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Results of operations
|
Dec 20, 2022 | Dec 20, 2022 |
| 10-Q | Quarterly report | Dec 20, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Dec 20, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2022 | Nov 29, 2022 |
| 10-Q/A | Amended quarterly report | Nov 25, 2022 | Mar 31, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- VVOS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Littleton, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1716166
- Former names
- Vivos BioTechnologies, Inc. (until Sep 29, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.